China NMPA Drug Inspection - Hubei Chengtian Pharmaceutical Co., Ltd. - Acyclovir cream

The Ningxia Food and Drug Administration released its 'Drug Quality Sampling Inspection Information Announcement (No. 04, 2017)' on June 9, 2017. This announcement details the outcomes of regional drug sampling inspections conducted under the 2017 work plan. The inspections covered 96 batches, encompassing 40 different drug varieties, which included 21 chemical drugs and 19 traditional Chinese medicine decoction pieces from various manufacturers and distribution points across the region.

Crucially, the inspections found that all tested drug batches met the required quality standards. The regulatory framework for these assessments primarily adhered to the Chinese Pharmacopoeia (2010 and 2015 editions) and other relevant national and local drug standards, such as Ministry of Health Drug Standards and specific National Drug Standards. As all products were found to be compliant, no violations or issues were identified, and consequently, no corrective actions were mandated for any company within this specific announcement. This publication serves to inform the public about the satisfactory quality of sampled pharmaceutical products in Ningxia.